# Apostle Inc

> Apostle Inc is a Pleasanton, California biotechnology company that develops nucleic acid isolation and preservation technologies for liquid biopsy. Its flagship magnetic-nanoparticle kit, Apostle MiniMax, extracts circulating cell-free DNA and RNA from blood for applications in early cancer detection, non-invasive prenatal testing, infectious disease research, and even astronaut biospecimen collection in commercial spaceflight. Founded in 2018 out of the Stanford StartX accelerator, the company sells reagents, automation instruments, and CLIA/CAP lab services to researchers and diagnostics developers worldwide.

- **Founded:** 2018
- **Headquarters:** Pleasanton, California, United States
- **Founders:** David Ge (Co-Founder, CEO & President), Bo Zhang (Co-Founder, VP of Chemistry), Xin Guo (Co-Founder, VP of Bioinformatics)
- **Team size:** ~21 employees
- **Products:** Apostle MiniMax, Apostle MagTouch, Apostle MiniEnrich, Apostle MiniGenomics, Apostle Triton
- **Notable:** Apostle MiniMax designated the official standard for astronaut biospecimen collection in U.S. commercial space missions (Axiom-2), published in npj Microgravity, May 2025, Technologies cited in Nature Medicine, Cancer Cell, Nature Communications, Science Translational Medicine and PNAS, Products featured in FDA-authorized COVID-19 diagnostic tests

## Products & services

- **Apostle MiniMax** — High-efficiency magnetic nanoparticle kit that extracts circulating cell-free DNA (and cfRNA) from plasma using manual or automated workflows, with high recovery, low variation and effective contaminant removal.
- **Apostle MagTouch** — Benchtop nucleic acid isolation automation system for high-throughput, hands-off extraction using Apostle magnetic-bead chemistry.
- **Apostle MiniEnrich** — High-resolution DNA size-enrichment and short-fragment selection technology built on the magnetic nano-platform.
- **Apostle MiniGenomics** — Genomic DNA and RNA isolation kits for a range of specimen types.
- **Apostle Triton** — Bioinformatics platform that applies machine learning to cfDNA/cfRNA sequencing data for biomarker and mutation analysis.
- **Apostle Lab (CRO & clinical services)** — CLIA-authorized, CAP-accredited laboratory offering cfDNA/cfRNA isolation services and contract research services.

## Achievements

- Apostle MiniMax designated the official standard for astronaut biospecimen collection in U.S. commercial space missions (Axiom-2), published in npj Microgravity, May 2025
- Technologies cited in Nature Medicine, Cancer Cell, Nature Communications, Science Translational Medicine and PNAS
- Products featured in FDA-authorized COVID-19 diagnostic tests
- ISO 13485:2016 and ISO 9001:2015 certified; CLIA-authorized and CAP-accredited (2021)
- Technologies reported to have served over 20 million people
- Recognized as Best of Pleasanton biotechnology (2024 and 2025)

## Latest updates

- **2025-05** — Apostle MiniMax named the official cfDNA extraction standard for astronaut biospecimen collection in commercial spaceflight (GENESTAR / Axiom-2, npj Microgravity).
- **2025-05** — MiniMax cited in new work on lung cancer detection and a prostate cancer clinical trial.
- **2025-10** — Apostle attended Haier Biomedical's 2025 Global Partner Conference.
- **2025-12** — MiniMax used to support global pediatric health work in Africa.
- **2026-02** — MiniMax applied to novel simultaneous prenatal cfDNA screening and nanoparticle-delivery research.
- **2026-05** — MiniMax cited in clinical research on colorectal cancer.

## Links

- Website: https://apostlebio.com
- LinkedIn: http://www.linkedin.com/company/apostle-inc
- Twitter/X: https://twitter.com/apostleinc

---

Profile page: https://yespress.io/apostle-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-13